280 related articles for article (PubMed ID: 16583462)
21. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
23. Oximes as pretreatment before acute exposure to paraoxon.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
J Appl Toxicol; 2019 Nov; 39(11):1506-1515. PubMed ID: 31264735
[TBL] [Abstract][Full Text] [Related]
24. Intravenous pyruvic acid application in minipigs partially protects acetylcholine-esteratic but not butyrylcholine-esteratic activity in plasma from inhibition by paraoxon.
Petroianu GA; Ewald V; Thyes C; Missler A; Maleck WH
J Appl Toxicol; 2003; 23(1):37-42. PubMed ID: 12518335
[TBL] [Abstract][Full Text] [Related]
25. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
Bartosova L; Kuca K; Jun D; Kunesova G
Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
[TBL] [Abstract][Full Text] [Related]
26. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
Musilova L; Kuca K; Jung YS; Jun D
Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE
J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016
[TBL] [Abstract][Full Text] [Related]
28. Pralidoxime inhibits paraoxon-induced depression of rocuronium-neuromuscular block in a time-dependent fashion.
Narimatsu E; Niiya T; Takahashi K; Yamauchi M; Yamakage M
Am J Emerg Med; 2012 Jul; 30(6):901-7. PubMed ID: 21871755
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
30. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
[TBL] [Abstract][Full Text] [Related]
31. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon.
Thiermann H; Eyer P; Worek F; Szinicz L
Toxicology; 2005 Oct; 214(3):190-7. PubMed ID: 16040183
[TBL] [Abstract][Full Text] [Related]
32. Comparative determination of the efficacy of bispyridinium oximes in paraoxon poisoning.
Žunec S; Radić B; Kuča K; Musilek K; Lucić Vrdoljak A
Arh Hig Rada Toksikol; 2015 Jun; 66(2):129-34. PubMed ID: 26110474
[TBL] [Abstract][Full Text] [Related]
33. Combined Pre- and Posttreatment of Paraoxon Exposure.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
Molecules; 2020 Mar; 25(7):. PubMed ID: 32230733
[TBL] [Abstract][Full Text] [Related]
34. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
[TBL] [Abstract][Full Text] [Related]
35. Pralidoxime and l-lactate effects in vitro on the inhibition of acetylcholinesterase by paraoxon: pralidoxime does not confer superior protection.
Petroianu G; Roth C; Beha U; Fisher J; Bergler W; Rüfer R
J Appl Toxicol; 2001; 21(1):7-13. PubMed ID: 11180275
[TBL] [Abstract][Full Text] [Related]
36. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
37. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods.
Kassa J; Cabal J
Toxicology; 1999 Feb; 132(2-3):111-8. PubMed ID: 10433374
[TBL] [Abstract][Full Text] [Related]
40. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
Jeong HC; Park NJ; Chae CH; Musilek K; Kassa J; Kuca K; Jung YS
Bioorg Med Chem; 2009 Sep; 17(17):6213-7. PubMed ID: 19665386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
